Showing results (4501-4510 of 27,716) with videos related to

Sort By:
Pageof 2,772
Vaccine|November 1, 1995
Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59G Ott, G L Barchfeld, G Van Nest
Vaccine|November 1, 1995
Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virusW S Gallichan, K L Rosenthal
Vaccine|November 1, 1995
Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccinesT Twomey, J Newman, T Burrage, et al.
Vaccine|December 1, 1995
Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatmentI Cropley, G Douce, M Roberts, et al.
Vaccine|December 1, 1995
A follow-up study of combined vaccination with plasma-derived and recombinant hepatitis B vaccines in infantsP I Lee, C Y Lee, L M Huang, et al.
Vaccine|December 1, 1995
Immunomodulatory effects of HSV2 glycoprotein D in HSV1 infected mice: implications for immunotherapy of recurrent HSV infectionL J York, D P Giorgio, E M Mishkin
Vaccine|December 1, 1995
Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccineM R Hilleman
Vaccine|December 1, 1995
Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 monthsM Böttiger
Vaccine|December 1, 1995
Caseous lymphadenitis vaccine development: site-specific inactivation of the Corynebacterium pseudotuberculosis phospholipase D geneM Tachedjian, J Krywult, R J Moore, et al.
Vaccine|December 1, 1995
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humansE D Kilbourne, R B Couch, J A Kasel, et al.
Pageof 2,772